Facebook Pixel

Comment Reply

Blogger (reply to Linda Fugate PhD)

Yes! This is an exciting time in the research for MS and the preliminaries look good. A third company is also working on an oral medication as well but they are not as far down the pipeline as Merck and Novartis. I'm hoping that one of the drugs turns out to be as effective and as safe as the current therapies. If we get a "yes" on both of those issues, we'll have a real winner. I'll be watching the progress!!!

August 11, 2009 - 8:37am

Reply

Image CAPTCHA
Enter the characters shown in the image.
By submitting this form, you agree to EmpowHER's terms of service and privacy policy